SAGE

Therapeutic Advances in Musculoskeletal Disease Template

Write in a clean editor, then format for Therapeutic Advances in Musculoskeletal Disease in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Therapeutic Advances in Musculoskeletal Disease format

Therapeutic Advances in Musculoskeletal Disease is a peer-reviewed journal published by SAGE, covering Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Osteoarthritis Treatment and Mechanisms.

PublisherSAGE
Reference styleAuthor–year (Harvard)
Author–year — (Smith, 2023) in the text
Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Therapeutic Advances in Musculoskeletal Disease, 12(3), pp. 45–58.

Formats any DOI in Therapeutic Advances in Musculoskeletal Disease style. No sign-up.

Publishes research inRheumatoid Arthritis Research and Therapies Spondyloarthritis Studies and Treatments Osteoarthritis Treatment and Mechanisms Bone health and osteoporosis research Systemic Lupus Erythematosus Research
ISSN1759-720X
Citation impact (2-yr)3.35
h-index70
i10-index485
Total citations22,959
Article processing charge$2,300
Open accessYes
Top institutions publishing hereCharité - Universitätsmedizin Berlin
Journal websiteus.sagepub.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Therapeutic Advances in Musculoskeletal Disease per year

17
2014
22
2015
24
2016
26
2017
21
2018
38
2019
85
2020
111
2021
107
2022
51
2023
55
2024
50
2025

Citation impact of Therapeutic Advances in Musculoskeletal Disease by publication year

587
2014
837
2015
1.2K
2016
1.6K
2017
1.2K
2018
1.2K
2019
2.3K
2020
2.3K
2021
1.9K
2022
587
2023
396
2024
125
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Therapeutic Advances in Musculoskeletal Disease

Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations

Jeremy Sokolove, Christin M. Lepus · 23 Jan 2013

Osteoarthritis (OA) has traditionally been classified as a noninflammatory arthritis; however, the dichotomy between inflammatory and degenerative arthritis is becoming less clear with the recognition of a plethora of ongoing immune processes within the OA joint and synovium. Synovitis is defined as inflammation of the synovial membrane and is characteristic of classical inflammatory arthritidies. Increasingly…

1,089 citations Cite SaveGo to paper →
Aging and bone loss: new insights for the clinician

Oddom Demontiero, Christopher Vidal, Gustavo Duque · 14 Dec 2011

It is well known that the underlying mechanisms of osteoporosis in older adults are different than those associated with estrogen deprivation. Age-related bone loss involves a gradual and progressive decline, which is also seen in men. Markedly increased bone resorption leads to the initial fall in bone mineral density. With increasing age, there is also…

Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis

Mary B. Goldring · 1 Jun 2012

Chondrogenesis occurs as a result of mesenchymal cell condensation and chondroprogenitor cell differentiation. Following chondrogenesis, the chondrocytes remain as resting cells to form the articular cartilage or undergo proliferation, terminal differentiation to chondrocyte hypertrophy, and apoptosis in a process termed endochondral ossification, whereby the hypertrophic cartilage is replaced by bone. Human adult articular cartilage is…

Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis

Bente Langdahl, Serge Ferrari, David W. Dempster · 6 Oct 2016

The adult skeleton is renewed by remodeling throughout life. Bone remodeling is a process where osteoclasts and osteoblasts work sequentially in the same bone remodeling unit. After the attainment of peak bone mass, bone remodeling is balanced and bone mass is stable for one or two decades until age-related bone loss begins. Age-related bone loss…

The role of Interleukin 6 in the pathophysiology of rheumatoid arthritis

Srinivasan Srirangan, Ernest Choy · 24 Aug 2010

Interleukin 6 (IL-6) is a pleiotropic cytokine with a pivotal role in the pathophysiology of rheumatoid arthritis (RA). It is found in abundance in the synovial fluid and serum of patients with RA and the level correlates with the disease activity and joint destruction. IL-6 can promote synovitis and joint destruction by stimulating neutrophil migration,…

Therapeutic Advances in Musculoskeletal Disease template — frequently asked questions

How do I write a paper in the Therapeutic Advances in Musculoskeletal Disease format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Therapeutic Advances in Musculoskeletal Disease template. When you export, DocuGuru compiles the paper into the official SAGE format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Therapeutic Advances in Musculoskeletal Disease use?
Therapeutic Advances in Musculoskeletal Disease uses Author–year (Harvard) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Therapeutic Advances in Musculoskeletal Disease, 12(3), pp. 45–58.
Do I need to know LaTeX to submit to Therapeutic Advances in Musculoskeletal Disease?
No. DocuGuru generates the sagej LaTeX class and compiles the PDF for you in the background, so you get a SAGE-ready Therapeutic Advances in Musculoskeletal Disease document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Therapeutic Advances in Musculoskeletal Disease template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Therapeutic Advances in Musculoskeletal Disease format with correct headings, figures, tables, and author–year citations.
Who publishes Therapeutic Advances in Musculoskeletal Disease?
Therapeutic Advances in Musculoskeletal Disease is a multidisciplinary journal published by SAGE. DocuGuru's Therapeutic Advances in Musculoskeletal Disease template matches SAGE's official submission format.
Can I export a submission-ready Therapeutic Advances in Musculoskeletal Disease PDF?
Yes — DocuGuru produces a PDF built with the official Therapeutic Advances in Musculoskeletal Disease template (the sagej class) that is ready to submit to SAGE, together with the matching LaTeX source files.
How much does the Therapeutic Advances in Musculoskeletal Disease template cost?
You can start writing in the Therapeutic Advances in Musculoskeletal Disease template for free. Exporting the final submission-ready Therapeutic Advances in Musculoskeletal Disease PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Therapeutic Advances in Musculoskeletal Disease template